Department of Cranio-Maxillofacial Surgery, University Hospital Münster, Albert-Schweitzer-Campus 1, W30, 48149, Münster, Germany.
Institute for Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.
Neurosurg Rev. 2020 Apr;43(2):793-800. doi: 10.1007/s10143-019-01125-0. Epub 2019 Jun 3.
Brain invasion (BI) is a new criterion for atypia in meningiomas and therefore potentially impacts adjuvant treatment. However, it remains unclear whether surgical practice and specimen characteristics influence histopathological analyses and the accuracy of detecting BI. Tumor location, specimen characteristics, and rates of BI were compared in meningioma samples obtained from 2938 surgeries in different neurosurgical departments but diagnosed in a single neuropathological institute. Non-skull base tumor location was associated with CNS tissue on the microscopic slides (OR 1.45; p < .001), increasing specimen weight (OR 1.01; p < .001), and remaining tissue not subjected to neuropathological analyses (OR 2.18; p < .001) but not with BI (OR 1.29; p = .199). Specimen weight, rates of residual tissue not subjected to histopathological analyses, of BI and of brain tissue, on the microscopic slides differed among the neurosurgical centers (p < .001, each). Frequency of BI was increased in one department (OR 2.07; p = .002) and tended to be lower in another (OR .61; p = .088). The same centers displayed the highest and lowest rates of brain tissue in the specimen, respectively (p < .001). Moreover, the correlation of BI with the neurosurgical center was not confirmed when only analyzing specimen with evidence of brain tissue in microscopic analyses (p = .223). Detection of BI was not correlated with the intraoperative use of CUSA in subgroup analyses. Rates of brain invasion in neuropathological analyses are not associated with tumor location but differ among some neurosurgical centers. Evidence raises that surgical nuances impact specimen characteristics and therefore the accuracy of the detection of BI.
脑侵犯(BI)是脑膜瘤非典型性的新标准,因此可能影响辅助治疗。然而,手术操作和标本特征是否会影响组织病理学分析和 BI 的检测准确性仍不清楚。在一个神经病理研究所诊断的 2938 例不同神经外科手术的脑膜瘤样本中,比较了肿瘤位置、标本特征和 BI 发生率。非颅底肿瘤位置与显微镜切片上的中枢神经系统组织相关(OR 1.45;p<.001),增加标本重量(OR 1.01;p<.001),未进行神经病理分析的剩余组织(OR 2.18;p<.001),但与 BI 无关(OR 1.29;p=.199)。标本重量、未进行组织病理学分析的剩余组织、BI 以及显微镜切片上脑组织的发生率在神经外科中心之间存在差异(p<.001,各)。一个部门的 BI 发生率增加(OR 2.07;p=.002),另一个部门的 BI 发生率趋于降低(OR.61;p=.088)。相同的中心显示标本中脑组织的发生率最高和最低(p<.001)。此外,当仅分析显微镜分析中有脑组织证据的标本时,BI 与神经外科中心的相关性未得到证实(p=.223)。在亚组分析中,BI 的检测与术中使用 CUSA 之间无相关性。在神经病理学分析中,BI 的发生率与肿瘤位置无关,但在一些神经外科中心之间存在差异。有证据表明,手术细节会影响标本特征,从而影响 BI 的检测准确性。